The Law Offices of Frank R. Cruz announces an investigation of ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI) on behalf of investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO LOST MONEY ON ICU MEDICAL, INC. (ICUI), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.

What Is The Investigation About?

On April 22, 2025, the FDA published a warning letter issued to ICU Medical stating that the Company had “made multiple changes to the Medfusion Model 4000 Syringe Infusion Pump and CADD Solis VIP Ambulatory Infusion Pump that could significantly affect the safety or effectiveness of these devices.” The warning letter stated the subject pumps were “adulterated” and “misbranded” and noted the Company’s modifications “can significantly impact the functionality of the device with respect to the infusion pumps delivery profile, alarm functionality, etc., and affect the device’s risk profile.”

On this news, ICU Medical’s stock price fell as much as 7% during intraday trading on April 22, 2025, thereby injuring investors.

Contact Us To Participate or Learn More:

If you purchased ICU Medical securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

The Law Offices of Frank R. Cruz

2121 Avenue of the Stars, Suite 800

Century City, California 90067

Call us at: 310-914-5007

Email us at: info@frankcruzlaw.com

Visit our website at: www.frankcruzlaw.com.

Follow us for updates on Twitter at twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250422146113/en/